Michael Bauer, MD
Cardiovascular Disease · Arlington Heights, ILNPI 1205832128
Payments from drug & device makers
Across 402 payments — averaging $1370.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$416K
- Amgen$45K
- AstraZeneca$32K
- Boehringer Ingelheim International GmbH$22K
- Merck$16K
- Astrazeneca UK Limited$9K
- plus $10K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 37 | $416,103 |
| Amgen | 22 | $44,968 |
| AstraZeneca | 13 | $31,749 |
| Boehringer Ingelheim International GmbH | 102 | $22,408 |
| Merck | 6 | $16,164 |
| Astrazeneca UK Limited | 2 | $9,357 |
| Heartflow, Inc. | 11 | $3,514 |
| Boston Scientific | 44 | $1,943 |
| GE HealthCare | 4 | $908 |
| Novartis | 54 | $900 |
| Edwards Lifesciences | 6 | $614 |
| Abbott | 14 | $479 |
| Johnson & Johnson | 21 | $335 |
| Pfizer | 14 | $293 |
| E.r. Squibb & Sons, L.L.C. | 9 | $256 |
| Esperion Therapeutics, Inc. | 5 | $195 |
| Actelion Pharmaceuticals US, Inc. | 2 | $146 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $128 |
| Bayer | 4 | $93 |
| Novo Nordisk | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| Lexicon Pharmaceuticals, Inc. | 3 | $64 |
| Sanofi-aventis U.S. LLC | 2 | $45 |
| Lundbeck LLC | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Teleflex LLC | 1 | $27 |
| Bridgebio Pharma, Inc. | 1 | $23 |
| Akcea Therapeutics, Inc. | 1 | $21 |
| Lantheus Medical Imaging, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Chiesi USA, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $16 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $13 |
| Tactile Systems Technology Inc | 1 | $12 |
| Medtronic | 1 | $12 |
| Cardinal Health 200 LLC | 1 | $12 |
How this compares
$551,082 in reported general payments places this provider in the 95th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Arlington Heights
- Steven LupovitchArlington Heights$2.6M
- Benjamin LumicaoChicago$3.7M
- Paul CremerChicago$2.9M
- Lokesh ChandraHazel Crest$2.7M
- Nitasha SarswatChicago$2M
- Alan BrownNaperville$1.5M
- Alexander AdlerPeoria$1.5M
- Clifford KavinskyMaywood$1.4M
- Sanjiv ShahChicago$1.2M
- Sandeep NathanChicago$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.